DK158352C - Fremgangsmaade til fremstilling af 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydrochlorid - Google Patents

Fremgangsmaade til fremstilling af 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydrochlorid

Info

Publication number
DK158352C
DK158352C DK042680A DK42680A DK158352C DK 158352 C DK158352 C DK 158352C DK 042680 A DK042680 A DK 042680A DK 42680 A DK42680 A DK 42680A DK 158352 C DK158352 C DK 158352C
Authority
DK
Denmark
Prior art keywords
chinazoline
furoyl
piperazinyl
dimethoxy
hydrochloride
Prior art date
Application number
DK042680A
Other languages
Danish (da)
English (en)
Other versions
DK158352B (da
DK42680A (da
Inventor
Erkki Juhani Honkanen
Aino Kyllikki Pippuri
Pekka Juhani Kairisalo
Heinrich Thaler
Maija Katriina Koivisto
Sirpa Anneli Tuomi
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of DK42680A publication Critical patent/DK42680A/da
Publication of DK158352B publication Critical patent/DK158352B/da
Application granted granted Critical
Publication of DK158352C publication Critical patent/DK158352C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK042680A 1979-01-31 1980-01-31 Fremgangsmaade til fremstilling af 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydrochlorid DK158352C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI790320 1979-01-31
FI790320A FI67699C (fi) 1979-01-31 1979-01-31 Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan

Publications (3)

Publication Number Publication Date
DK42680A DK42680A (da) 1980-08-01
DK158352B DK158352B (da) 1990-05-07
DK158352C true DK158352C (da) 1990-10-08

Family

ID=8512343

Family Applications (1)

Application Number Title Priority Date Filing Date
DK042680A DK158352C (da) 1979-01-31 1980-01-31 Fremgangsmaade til fremstilling af 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydrochlorid

Country Status (21)

Country Link
US (1) US4271300A (no)
JP (1) JPS55104280A (no)
AT (1) AT374475B (no)
BE (1) BE881297A (no)
CA (1) CA1128945A (no)
CH (1) CH644605A5 (no)
CS (1) CS214692B2 (no)
DD (1) DD148952A1 (no)
DE (1) DE3002553A1 (no)
DK (1) DK158352C (no)
FI (1) FI67699C (no)
FR (1) FR2447920A1 (no)
GB (1) GB2041932B (no)
HU (1) HU181016B (no)
NL (1) NL190701C (no)
NO (1) NO152298C (no)
PL (1) PL126994B1 (no)
SE (1) SE430692B (no)
SU (1) SU900812A3 (no)
YU (1) YU41498B (no)
ZA (1) ZA80501B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1390015A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv 4-amino-quinazoline compounds
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI58124C (fi) * 1976-12-15 1980-12-10 Orion Yhtymae Oy Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan
FI58125C (fi) * 1976-12-15 1985-01-02 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan

Also Published As

Publication number Publication date
CS214692B2 (en) 1982-05-28
NO152298B (no) 1985-05-28
CH644605A5 (de) 1984-08-15
PL221684A1 (no) 1980-10-20
ATA19580A (de) 1983-09-15
SE430692B (sv) 1983-12-05
SE8000777L (sv) 1980-08-01
NL190701C (nl) 1994-07-01
DE3002553C2 (no) 1988-10-27
BE881297A (fr) 1980-05-16
AT374475B (de) 1984-04-25
NO152298C (no) 1985-09-04
PL126994B1 (en) 1983-09-30
FR2447920A1 (fr) 1980-08-29
FI67699B (fi) 1985-01-31
NL190701B (nl) 1994-02-01
ZA80501B (en) 1981-02-25
FR2447920B1 (no) 1982-12-03
JPS55104280A (en) 1980-08-09
DK158352B (da) 1990-05-07
FI67699C (fi) 1985-05-10
YU41498B (en) 1987-08-31
GB2041932A (en) 1980-09-17
GB2041932B (en) 1982-10-27
US4271300A (en) 1981-06-02
NO794279L (no) 1980-08-01
DE3002553A1 (de) 1980-08-07
DD148952A1 (de) 1981-06-17
JPS6310955B2 (no) 1988-03-10
YU5880A (en) 1983-02-28
DK42680A (da) 1980-08-01
HU181016B (en) 1983-05-30
SU900812A3 (ru) 1982-01-23
FI790320A (fi) 1980-08-01
CA1128945A (en) 1982-08-03
NL8000289A (nl) 1980-08-04

Similar Documents

Publication Publication Date Title
DK233880A (da) Fremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4,-triaziner
DK155946C (da) Fremgangsmaade til fremstilling af 4,1',6'-trichlor-4,1',6'-tridesoxygalactosaccharose
DK262980A (da) Fremgangsmaade til fremstilling af 2,3-dihydro-2,6,7-trisubstituerede 5-acylbenzofuraner
DK469379A (da) Fremgangsmaade til fremstilling af 1-hydroxylerede 5,6-vitamind-forbindelser
DK573282A (da) Fremgangsmaade til fremstilling af 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl)-butyl)-1-piperazinyl)pyridiner
DK156635C (da) Analogifremgangsmaade til fremstilling af 24,24-difluor-25-hydroxycholecalciferol
DK158352C (da) Fremgangsmaade til fremstilling af 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydrochlorid
DK308180A (da) Fremgangsmaade til fremstilling af 2,3-dihydro2,2-dimethyl-7-hydroxybenzofuran
DK174380A (da) Fremgangsmaade til fremstilling af 2!,6!adialkyl-n-alkoxymethyl-2-chlor-acetanillider
DK105777A (da) Fremgangsmade til fremstilling af 2-(2,2-dicyclohexylethyl)piperidin
DK153487C (da) Analogifremgangsmaade til fremstilling af 2-(perhydro-1,4-diazino)-pyrimidooe5,4-daapyrimidinderivater
DK375380A (da) Fremgangsmaade til fremstilling af 5-(chlorphenyl)-6h-1,3,4-thiadiazin-2-aminer
DK140578A (da) Fremgangsmaade til fremstilling af 2-(2!,2!,-trihalogenethyl)-4-halogencyclobutan-1-oner.
DK337280A (da) Fremgangsmaade til fremstilling af 4-(naphthalenyloxy)piperidin-derivater
DK375480A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-3-thioler
NO147244C (no) Fremgangsmaate til fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin
DK153789C (da) Fremgangsmaade til fremstilling af 2,3-dihydro-2,2-dimethyl-7-hydroxy-benzofuran
DK105679A (da) Fremgangsmaade til fremstilling af 2-(2,2-dimethyl-3-buten-1-yl)-2-oxazoliner
DK214479A (da) Fremgangsmaade til fremstilling af 2,4-diamono-5-(3,5-dialkyl-4-hydroxybenzyl) pyrimidiner
DK412880A (da) Fremgangsmaade til fremstilling af 4-(4!-orthochlorphenyl-phenyl)-4-oxo-2-methylensmoersyre
DK212080A (da) Fremgangsmaade til fremstilling af 2,2-dialkyl-4-methyl-5,5-dialkyl-3-formyl-3-pyrrolin
DK149887C (da) Fremgangsmaade til fremstilling af 2-oxo-dihydrobenzo(d)(1,3)oxaziner
DK237079A (da) Fremgangsmaade til fremstilling af 2,3-dihydro-2-methyl-3-(2-(dimethylamino) propyl)-3-phenyl-1h-indol-1-carboxaldehyd
NO147912C (no) Fremgangsmaate for fremstilling av 2-(4-(2-furoyl)-piperazin-1-yl)-4-amino-6,7-dimetoksykinazolin
DK152124C (da) Analogifremgangsmaade til fremstilling af 1-oe1-(3,4-dimethoxyphenyl)-3-aminopropylaa-6,7-dimethoxyisoquinolin-derivater

Legal Events

Date Code Title Description
PBP Patent lapsed